|
| |
Momenta PharmaceuticalsMomenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. We are also utilizing our ability to sequence, or analyze the molecular structure of, sugars to create technology-enabled generic versions of complex sugar-based products. Our most advanced product candidate, M-Enoxaparin, is designed to be a technology-enabled generic version of Lovenox®, a widely prescribed low molecular weight heparin, or LMWH. Our novel product candidates include M118, a LMWH for the treatment of acute coronary syndromes that has been designed to possess specific biological attributes as well as a technology that has been designed to use specific sugar sequences to improve the non-invasive delivery of drugs such as therapeutic proteins.
| Contact Details: |
| 675 West Kendall Street |
| Cambridge |
| Massachusetts |
| 02142 |
| United States of America |
| Tel: | 617.491.9700 |
| Fax: | 617.621.0431 |
| Email: | info@momentapharma.com |
| WWW: | www.momentapharma.com/
|
|
Loading...
|
Recent Publications by Momenta Pharmaceuticals: |  |
M118 - A rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes.
The initial choice of anticoagulant therapy administered in emergency... | 6th November, 2009
| Momenta Pharmaceuticals, Inc, 675 West Kendall St., Cambridge, MA 02142,
| Thromb Haemost. 2009 Nov;102(5):900-6.
DOI Direct Link |
Overexpression of Merlin in B16F10 mouse melanoma cells reduces their metastatic activity: role of the cell surface heparan sulfate glycosaminoglycans.
Merlin, the protein product of the neurofibromatosis type 2 gene (NF2)... | 31st July, 2008
| Momenta Pharmaceuticals, Inc., Cambridge, MA 02142, USA.
| Int J Oncol. 2008 Jun;32(6):1237-43.
|
Contaminated heparin associated with adverse clinical events and activation of the contact system.
BACKGROUND: There is an urgent need to determine whether oversulfated... | 20th June, 2008
| Momenta Pharmaceuticals, the Harvard-Massachusetts Institute of Technology
| N Engl J Med. 2008 Jun 5;358(23):2457-67. Epub 2008 Apr 23.
DOI Direct Link |
High level expression of proteins using sequences from the ferritin heavy chain gene locus.
An expression vector has been generated using a gene highly expressed... | 14th March, 2007
| Momenta Pharmaceuticals, Inc., Cambridge, MA 02142, United States.
| J Biotechnol. 2007 Jan 30;128(1):50-60. Epub 2006 Nov 2.
DOI Direct Link |
Genetically engineered mouse melanoma and mouse Lewis lung carcinoma models.
Melanoma B16-F10 cells and Lewis lung carcinoma LL/2 cells were engineered... | 13th July, 2005
| Momenta Pharmaceuticals Inc., Cambridge, MA 02142, USA.
| Int J Oncol. 2005 May;26(5):1233-9.
|
→View more Momenta Pharmaceuticals research publications. |
Press Releases on Momenta Pharmaceuticals:
|
 |
| Reportlinker Adds World Neurodegenerative Diseases Market 2009-2024 |
3rd November, 2009 |
Reportlinker |
-- Rilutek.
In our pipeline analyses we include emerging therapeutics such as stem cells, gene therapy and monoclonal antibodies, among other prominent developments.
Detailed analysis of the
|
| Marsha Fanucci Joins Ironwood Board of Directors |
27th October, 2009 |
Ironwood Pharmaceuticals, Inc. |
CAMBRIDGE, Mass., Oct. 27 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that Marsha Fanucci has joined its Board of Directors. Ms. Fanucci served at Millennium Pharmaceuticals, Inc.
|
| Reportlinker Adds World Market for Biosimilars and the Potential for US Follow-on Biologics, The Report |
24th September, 2009 |
Reportlinker |
-- Current market size and forecasts for biogenerics in Europe and Rest of
World Markets
-- Review of Marketed Biological Drugs with Expired Patents
-- Review of
|
| Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years |
2nd July, 2009 |
Cardinal Health, Inc. |
DUBLIN, Ohio, July 2 /PRNewswire-FirstCall/ -- Cardinal Health today announced that Bruce L. Downey will join the company's board of directors effective upon the completion of the planned spinoff
|
| Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications |
29th June, 2009 |
aTyr Pharma |
aTyr Pharma Targets for Novel Biotherapeutics Based On Naturally Resected tRNA Synthetases
SAN DIEGO, June 29 /PRNewswire/ -- Pangu BioPharma, a subsidiary of aTyr Pharma in Hong Kong, today
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 287 times since April 2007, the link to the organisation's website has been followed 34 times Search for more companies in Cambridge Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Momenta Pharmaceuticals |
